The Stimulation Phase: Daily Routine, Injection Schedule, Side Effects, and Dose Adjustments
The stimulation phase of IVF lasts 8 to 14 days and involves daily hormone injections to grow multiple follicles. This guide covers what each day looks like, common side effects, why doses change, and what to expect physically and logistically.
What stimulation is and why it matters
In a natural menstrual cycle, a group of follicles begins growing each month, but usually only one becomes dominant and ovulates. The others regress. IVF stimulation uses injectable gonadotropins to override this selection mechanism, allowing multiple follicles to grow simultaneously so that multiple eggs can be retrieved.
More eggs give the lab more material to work with. Not every egg will fertilize, not every fertilized egg will develop to blastocyst, and not every blastocyst will be chromosomally normal. The stimulation phase is about maximizing the starting number so that the inevitable attrition at each downstream step still leaves viable embryos for transfer.
The medications used are synthetic or purified versions of the hormones the body naturally produces to drive follicle growth, primarily FSH and sometimes LH. The starting dose is chosen based on age, AMH, antral follicle count, body weight, and prior cycle history if applicable.
What a typical day looks like
During stimulation, the daily routine centers on two things: taking the injections at roughly the same time each evening and attending monitoring appointments every one to three days.
Most gonadotropin injections are subcutaneous, given with a small-gauge needle into the fatty tissue of the lower abdomen. Some patients prefer to inject at the same location each day. Others rotate injection sites to reduce soreness. The injection itself takes seconds. Preparing the medication, whether it is a pre-filled pen or a vial requiring mixing, takes a few minutes.
Once the GnRH antagonist is added to the protocol, usually around stimulation day five or six, patients give two injections per evening instead of one. Some antagonist medications are packaged as pre-filled syringes, which simplifies the process.
Monitoring appointments happen in the morning, typically between 7 and 9 AM, because blood results need to be available by early afternoon so the clinic can communicate any dose changes before that evening's injection. Each appointment includes a transvaginal ultrasound and a blood draw. The visit itself usually lasts 20 to 30 minutes, though waiting time varies by clinic.
The medications and what each one does
Gonadotropins (FSH with or without LH). These are the main stimulation drugs. Brand names include Gonal-F, Follistim, Menopur, and Pergoveris, among others. They directly stimulate follicle growth. The dose is measured in international units (IU) and typically ranges from 150 to 450 IU per day, though lower and higher doses are used in specific situations.
GnRH antagonist. Brands include Cetrotide and Ganirelix. Added several days into stimulation to prevent a premature LH surge that would trigger ovulation before retrieval. Taken daily once started, usually until the trigger shot.
Trigger shot. Given 34 to 36 hours before retrieval to complete egg maturation. Options include HCG (Ovidrel, Pregnyl), a GnRH agonist (Lupron), or a dual trigger combining both. The choice depends on OHSS risk, follicle count, and estradiol level.
Some protocols also include pre-treatment medications, such as oral contraceptives or estrogen patches, in the weeks before stimulation begins. These are used for cycle scheduling and to synchronize follicle development.
Common side effects during stimulation
Bloating and abdominal fullness. As follicles grow, the ovaries enlarge. By the end of stimulation, each ovary may be several times its normal size. This causes noticeable bloating, pressure, and a sensation of fullness in the lower abdomen. Wearing loose clothing and avoiding vigorous exercise helps.
Injection-site reactions. Mild redness, bruising, or soreness at the injection site is common and usually resolves within a day or two. Rotating injection sites and applying ice briefly before injecting can reduce discomfort.
Headaches. Hormonal fluctuations during stimulation can trigger headaches. Over-the-counter acetaminophen (Tylenol) is generally considered safe. Ibuprofen and other NSAIDs should be avoided because they may interfere with ovulation and implantation.
Mood changes. Elevated estrogen levels can amplify emotional responses. Irritability, anxiety, tearfulness, and difficulty concentrating are all reported during stimulation. These are temporary and resolve after retrieval.
Breast tenderness. Rising estrogen causes breast tissue changes similar to premenstrual symptoms, often more pronounced because estrogen levels during stimulation are much higher than in a natural cycle.
Fatigue. Hormone levels, disrupted sleep from bloating or anxiety, and the logistics of daily appointments can all contribute to tiredness during stimulation. Planning a lighter workload for the last few days of stimulation is practical advice that many patients wish they had received earlier.
Why and how doses change
The starting dose is an educated estimate. The clinic chooses it based on predictive factors, but the real answer comes from monitoring. Dose adjustments are the norm, not the exception.
If follicles are growing slowly and estradiol is low relative to follicle count, the dose may be increased by 75 to 150 IU. If follicles are growing unevenly, with a few pulling ahead while the majority lag, the clinic may hold the dose to let the smaller ones catch up, a strategy sometimes called coasting in a different context.
If the response is too strong, with estradiol climbing rapidly and a large number of follicles growing, the dose may be decreased. In high-risk situations, the clinic may also start or increase the antagonist earlier, switch the trigger from HCG to a GnRH agonist, or plan a freeze-all cycle to reduce OHSS risk.
Each dose change is based on the latest monitoring data. Patients sometimes feel anxious when doses change, interpreting it as a sign that something is wrong. In most cases, dose adjustment is the system working as designed, not a red flag.
Exercise, sex, and activity during stimulation
As the ovaries enlarge, the risk of ovarian torsion, where an enlarged ovary twists on its blood supply, increases. For this reason, most clinics advise against high-impact exercise, jumping, heavy lifting, and vigorous twisting movements during the second half of stimulation. Walking, gentle yoga, and light activity are generally fine.
Sexual intercourse during stimulation is typically restricted after mid-cycle, both because of torsion risk and because there is a possibility of ovulating before retrieval if suppression is not complete. With a large number of mature follicles, unprotected intercourse could also theoretically result in a high-order multiple pregnancy.
Alcohol consumption is generally discouraged during IVF, though the evidence for harm from moderate intake during stimulation specifically is limited. Caffeine in moderate amounts, roughly one to two cups of coffee per day, is considered acceptable by most clinics.
What happens at the end of stimulation
When monitoring shows that enough follicles have reached 17 to 20 mm in diameter and estradiol is in an appropriate range, the clinic schedules the trigger shot. Trigger timing is precise: the injection is given exactly 34 to 36 hours before the scheduled retrieval time. This means the trigger is usually an evening injection with a retrieval the following morning-after-next.
Patients typically take their last gonadotropin injection one or two days before trigger, and the last antagonist injection the evening before or the morning of trigger, depending on the protocol. After trigger, no more stimulation injections are needed.
The clinic provides specific instructions about timing, preparation for retrieval (fasting, what to wear, who to bring), and what medications to take or stop. Following the trigger timing exactly is critical. A mistimed trigger, even by a few hours, can result in premature ovulation or immature eggs.
Logistics for patients doing IVF abroad
For patients starting stimulation at home and traveling to the clinic for retrieval, the handoff between the local monitoring clinic and the treating clinic is the most important logistical element. Both teams need to use the same units for blood work, agree on communication protocols, and have a clear plan for when the patient should travel.
Most international IVF protocols ask the patient to arrive three to five days before expected retrieval. This gives the treating clinic time to do its own monitoring, make final dose adjustments, and schedule the trigger based on its own assessment. Arriving too late can force a suboptimal trigger timing or require the patient to delay by a day.
Patients should travel with their medications in carry-on luggage, with a letter from the prescribing clinic explaining the medications and their purpose. Most fertility medications do not require refrigeration during travel if kept cool, but specific storage requirements should be confirmed with the pharmacy or clinic.
Frequently asked questions
How long does IVF stimulation last?
Stimulation typically lasts 8 to 14 days, with 10 to 12 being the most common range. The duration depends on how quickly and evenly follicles respond to medication. Slower responders may need a few extra days. The clinic adjusts timing based on monitoring, not a fixed calendar.
Do IVF injections hurt?
Subcutaneous injections, which are given with a small needle just under the skin of the abdomen, are generally described as mild stinging or pinching. Intramuscular injections, such as progesterone in oil, use a longer needle and can cause more discomfort. Most patients tolerate the injections well once they learn the technique, which usually takes two or three days.
Why would my dose be changed mid-cycle?
Dose changes are driven by monitoring results. If follicles are growing too slowly, the dose goes up. If follicles are growing too quickly or estradiol is rising rapidly, the dose goes down. The goal is a cohort of follicles reaching maturity at roughly the same time while keeping hormone levels in a safe range.
Evidence changes. Ask your clinician what has changed since you last reviewed your plan.
Exploring treatment abroad?
This site covers treatment science and clinical education. For Colombia-specific clinic vetting, costs, travel logistics, and legal framework, see ColombianIVF.com and ColombiaMedical.co.
Ask about Colombia IVF medication costs in Colombia vs the USRelated: IVF Monitoring Bloodwork: What Your Numbers Mean
Sources and further reading
Clinical content on this page reflects current ASRM, ESHRE, and peer-reviewed literature as of September 2026. Individual treatment decisions depend on diagnosis, age, ovarian response, sperm factors, uterine evaluation, lab performance, and prior cycle history. Nothing here replaces consultation with a board-certified reproductive endocrinologist.